Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. NVDA
4. SPCX
5. USO
6. NDAQ
7. ELVN
8. BBW
9. RKLB
10. LEN

Go back to Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

February 18, 2022 11:50 AM EST

DUBLIN, Feb. 18, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Freezor and Freezor Xtra Cardiac Cryoablation Catheters are approved by the U.S. Food and Drug Administration (FDA) and are the only ablation catheters approved to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

AVNRT is the most common form of supraventricular tachycardia (SVT), and is a life-threatening abnormal heart rhythm, with 89,000 cases each year and growing. Nearly 35% of AVNRT cases occur in pediatrics, or, children under the age... More